Oncternal Therapeutics Inc (NAS:ONCT)
$ 8.179 -0.456 (-5.28%) Market Cap: 24.21 Mil Enterprise Value: -9.73 Mil PE Ratio: 0 PB Ratio: 0.80 GF Score: 50/100

Q4 2019 Oncternal Therapeutics Inc Earnings Call Transcript

Mar 16, 2020 / 08:30PM GMT
Release Date Price: $66.6 (+3.26%)
Operator

Greetings, ladies and gentlemen, and welcome to the Oncternal Therapeutics fourth quarter financial results conference call. (Operator Instructions) As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, Richard Vincent, Chief Financial Officer. Thank you, sir. You may begin.

Richard G. Vincent
Oncternal Therapeutics, Inc. - CFO

Thank you, operator. Good afternoon, everyone, and thanks for joining us. I'd like to welcome you to our business update and 2019 fourth quarter and full year financial results conference call.

Joining me on the call this afternoon are our President and CEO, Dr. Jim Breitmeyer; and our Chief Medical Officer, Dr. Frank Hsu.

Today's call includes a business update and discussion of our 2019 fourth quarter and full year results, which will be followed by Q&A.

Please note that today's press release is available on the Investor Relations section of Oncternal's website. We plan to file our 10-K for the full year 2019 today. A replay of today's earnings call

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot